Logo
x

Search

Subscribe Now

genmab

Enhancing Capabilities: Tahi Ahmadi from Genmab in a Riveting Dialogue Exchange with PharmaShots

Enhancing Capabilities: Tahi Ahmadi from Genmab in a Riveting Dialogue Exchange with PharmaShots

  • July 29, 2024
PharmaShots' Key Highlights of Second Quarter 2024

PharmaShots' Key Highlights of Second Quarter 2024

  • July 2, 2024
Genmab to Acquire ProfoundBio for Enhancing its Oncology Portfolio

Genmab to Acquire ProfoundBio for Enhancing its Oncology Portfolio

  • April 3, 2024
Genmab Receives MHLW Approval for Epkinly (epcoritamab) for Adults Patients with Large B-Cell Lymphoma

Genmab Receives MHLW Approval for Epkinly (epcoritamab) for Adults Patients with Large B-Cell Lymphoma

  • September 25, 2023
Genmab and Seagen Report P-III Trial (innovaTV 301) Results of Tivdak (tisotumab vedotin-tftv) for Recurrent or Metastatic Cervical Cancer

Genmab and Seagen Report P-III Trial (innovaTV 301) Results of Tivdak (tisotumab vedotin-tftv) for Recurrent or Metastatic Cervica...

  • September 5, 2023
Tahi Ahmadi and Asud Khaliq Share their Views on EPKINLY (epcoritamab) U.S. FDA Approval in DLBCL

Tahi Ahmadi and Asud Khaliq Share their Views on EPKINLY (epcoritamab) U.S. FDA Approval in DLBCL

  • August 2, 2023
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.